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Abstract
Mycobacterium tuberculosis (MTB) infection is the ninth leading cause of death worldwide,
with many individuals with undiagnosed active or latent disease. The presence of parenchymal
lung disease, such as interstitial lung disease (ILD), has been suggested to increase the risk of
pulmonary tuberculosis (TB). In the clinical setting of ILD, the diagnosis of an underlying MTB
infection may be challenging due to the interstitial process and underlying fibrosis, which may
mask the infection. An atypical presentation and misleading radiological patterns may delay the
diagnosis of the underlying MTB infection. Herein, we describe a unique case of ILD
complicated by active MTB infection in an 84-year-old male, which presented as a diagnostic
and clinical challenge. Eventually, due to hypoxia and respiratory failure, the patient expired.
Categories: Internal Medicine, Infectious Disease, Pulmonology
Keywords: interstitial lung disease, mycobacterium, tuberculosis, infectious disease, pulmonary
diseases, radiology
Introduction
Mycobacterium tuberculosis (MTB) infection is the ninth leading cause of death worldwide and
the leading cause from a single infectious agent, ranking above human immunodeficiency virus
infection/acquired immune deficiency syndrome (HIV/AIDS) [1]. With approximately one-third
of the world’s population having been exposed to MTB, there exist many individuals with
undiagnosed active or latent disease [1]. Susceptibility to infection may be due to a compromise
of the immune system, the use of immune-modulating drugs, or an underlying disease such as
bronchogenic cancer [2]. It has also been described in the literature that the presence of
parenchymal lung disease, such as idiopathic pulmonary fibrosis (IPF), a type of interstitial
lung disease (ILD), increases the risk of pulmonary tuberculosis (TB) [3].
ILD is an umbrella term for a group of disorders that present with a similar constellation of
signs and symptoms, including progressively worsening dyspnea on exertion, dry cough, and
bibasilar inspiratory crackles on auscultation. Aside from IPF, other causes of ILD include
occupational work exposures, fungal etiology, or atypical bacterial pneumonia. In the clinical
setting of ILD, the diagnosis of an underlying MTB infection may be challenging due to the
interstitial process and underlying fibrosis, which may mask the infection. Herein, we describe
a unique case of ILD complicated by an active MTB infection in an 84-year-old male, which
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presented as a diagnostic and clinical challenge.
Case Presentation
An 84-year-old, Ecuadorian, non-smoker, Spanish-speaking male with a past medical history of
dementia, hypertension, and hyperparathyroidism presented with cough productive of
purulent sputum associated with persistent shortness of breath and non-exertional retrosternal
chest pain for the past five days. The patient denied any fever, chills, or night sweats. Upon
further questioning, the patient revealed that he was an ex-farm worker who worked in sugar
cane fields where he was exposed to smoke daily for approximately 30-35 years. As per a family
member, there has been no recent weight loss or hemoptysis noted. Prior to presentation, the
patient was evaluated by his primary care physician and was prescribed a course of
azithromycin without relief of his symptoms. Chest radiography revealed possible left lower
lobe pneumonia and the patient was referred for admission to the hospital for the
administration of intravenous antibiotics.
On presentation at the hospital, initial vital signs were a blood pressure of 141/79 mmHg, a
heart rate of 112 beats per minute, an oxygen saturation of 96% on room air, a respiratory rate
of 14 breaths per minute, and a temperature of 37.6 degrees Celsius. On physical examination,
the patient seemed to be fatigued with the presence of bibasilar rhonchi on auscultation. The
rest of the physical exam was unremarkable. Initial lab results are shown in Table 1.
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Investigation Results (normal values)
Total Bilirubin 2 (0.0-1.2mg/dl)
Direct Bilirubin 1.8 (0.0-0.3mg/dl)
Alkaline Phosphatase 230 (40-130U/L)
Albumin 2.2 (3.5-5.2 g/dl)
Aspartate Amino Transferase/Serum Glutamic-Oxaloacetic Transaminase (AST/SGOT) 25 (5-41U/L)
Alanine Aminotransferase/ Serum Glutamate-Pyruvate Transaminase (ALT/SGPT) 17 (5-40U/L)
Sodium Level 141 (136-145mmol/l)
Potassium Level 4.5 (3.5-5.1mmol/l)
Carbon Dioxide Level 19 (22-29mmol/l)
Chloride Level 106 (98-107mmol/l)
Blood Urea Nitrogen 42 (8-23mg/dl)
Creatinine 1.1 (0.70-1.20mg/dl)
Calcium Level 10.1 (8.6-10.4mg/dl)
Random Glucose 127 (74-99mg/dl)
Total Creatine Kinase 14 (20-200U/L)
Troponin I <0.017 (0.010-0.030ng/ml)
White Blood Count 24.5 (4.80-10.80K/uL)
Hematocrit 34.1 (40-50%)
Hemoglobin 10.5 (13.3-17.7g/dl)
Platelet Count 74 (150-400K/uL)
Mean Corpuscular Volume 92.4 (80-100fl)
Prothrombin Time International Ratio 1.17 (0.87-1.13)
Activated Partial Thromboplastin time 26.6 (25-35 second)
Prothrombin Time 13.4 (10-13 second)
TABLE 1: Laboratory results
The patient was admitted and intravenous ceftriaxone and azithromycin were initiated, with a
working diagnosis of community-acquired pneumonia. Approximately 36 hours into
hospitalization, the patient became dyspneic and acutely hypoxic with oxygen saturation
dropping to 80% on room air and the patient was started on high flow oxygen via nasal cannula
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(HFNC). A repeat chest x-ray showed multi-lobular pneumonia (Figure 1). Subsequent
computed tomography (CT) of the chest showed diffuse bilateral scattered patchy and nodular
opacities, with underlying scarring and fibrosis consistent with interstitial lung disease (Figure
2), according to radio-clinical criteria.
FIGURE 1: Chest radiography showing increased reticular
markings and areas of consolidation suggestive of multilobular
pneumonia
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FIGURE 2: Computed tomography of the chest showing diffuse
bilateral scattered patchy and nodular opacities throughout the
lungs, possibly representative of multifocal pneumonia
throughout the lungs
Arrows point to consolidation with a pneumonia-like pattern
Despite high flow oxygen, the patient’s condition continued to decline, becoming more
hypoxic. HFNC was changed to bi-level positive airway pressure, as the patient remained
hypoxic on HFNC. Additional testing, such as respiratory viral panel, mycoplasma,
streptococcus pneumonia, and HIV were all negative. Gram staining of the sputum culture was
also found to be negative. Bronchoscopy was declined by family members due to the invasive
nature of the procedure. Eventually, the sputum culture for acid-fast bacilli (AFB) returned to
be positive. The patient was expectantly started on rifampin, isoniazid, pyrazinamide, and
ethambutol (RIPE) therapy.
Despite targeted therapy, the patient further deteriorated, requiring intubation and was
transferred to the intensive care unit due to hypoxic respiratory failure. The patient was started
and maintained on RIPE therapy due to the AFB positive sputum culture. The patient continued
to remain hypoxic despite the RIPE therapy and expired six weeks after admission. It was
thought that the combination of interstitial process combined with the overlapping
mycobacterial infection caused the demise of this patient.
Discussion
We highlight a case of an 84-year-old male with underlying interstitial lung disease, which was
further complicated by an active MTB infection. The diagnosis and management of active
tuberculosis infections in patients with an underlying interstitial process may prove
challenging, which demonstrates the uniqueness of this case. Very limited data are available
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exploring the relationship of MTB in ILD patients. In a study by Chung MJ et al., 143
consecutive patients with IPF were analyzed and it was found that the incidence of tuberculosis
in patients with IPF was more than five times higher than that of the general population [3]. In
addition, the most common CT findings in the study were subpleural nodules, lobar and
segmental consolidations that are atypical manifestations for MTB, as they mimic lung cancer
or bacterial pneumonia [3]. In our case, CT was described as diffuse, bilateral, scattered, patchy,
and nodular opacities with confluence in the left apex measuring approximately 3.7 cm,
possibly representing multifocal pneumonia. Due to such a pattern on radiological
exams, wide-spectrum antimicrobial therapy was warranted. Further complicating our case was
the absence of the typical presentation of an active MTB infection.
In an earlier study examining the relationship of chronic ILD and tuberculosis, Shachor et al.
retrospectively reviewed 162 cases from 1970 to 1984 and found that 5%-6.2 % patients with
chronic ILD have a positive culture for MTB, which was found to be approximately 4.5 times the
incidence in the general population [4]. This indicates that the MTB incidence is higher in the
ILD patients. From the literature, it seems apparent that the incidence of MTB in the ILD
population is more than what is normally seen in the general population. However, not much
data is available for other mycobacterial infections, which may also demonstrate a deleterious
effect in the setting of ILD. In a 2012 study by Park et al. of 795 IPF patients, pulmonary
infections with Mycobacterium tuberculosis (MTB) and non-tuberculous mycobacterium (NTM)
were found in 35 (4.4%) and 16 patients (2.0%), respectively, which was higher than the general
population. In addition, as expected, TB was more common in patients who were treated with
immunosuppressants and among the 51 IPF patients who had mycobacterial infections,
nine (18%) died during follow-up, three due to the progression of pulmonary tuberculosis [5].
Our patient proved to be a clinical challenge due to radiological findings that were consistent
with changes seen in pneumonia. However, with a history of being an Ecuadorian farm worker
who presented with pleuritic chest pain, hypoxia, and shortness of breath, ILD secondary to
occupational hazards was also part of the differential. Appropriate measures were taken in
order to treat the ILD without any improvement in the clinical picture. During the rapid
deterioration of our patient, the eventual culture of the sputum was found to be positive for
MTB. Despite the initiation of RIPE therapy alongside treatment measures for the ILD, the
patient expired. The decision to culture the sputum was a fortuitous one, as the patient did not
present with the traditional features of tuberculosis such as a cough, fever, chills, night sweats,
weight loss, or hemoptysis. In fact, it has been observed that up to a third of MTB patients
present with atypical symptoms (lack of greater than weeks of cough or fever) [6]. A further
exacerbation of the situation could be attributed to the fact that older patients (>65 years
old), as well as those who do not present without respiratory symptoms, are misdiagnosed more
frequently, delaying the correct diagnosis of pulmonary tuberculosis [7]. The progression of ILD
is acknowledged to be heterogeneous, with some patients remaining stable for prolonged
periods, others showing more rapid steady progression, and still others succumbing to acute
exacerbation [8]. It is quite possible that an acute exacerbation of the ILD was the onus for the
reactivation of his latent tuberculosis or vice versa. The specific interaction between ILD and
tuberculosis is still unknown, however, it has been suggested that a diffusely damaged lung
parenchyma increases the susceptibility to dormant tuberculosis [4]. It is generally understood
that interferon (IFN)-gamma and tumor necrosis factor (TNF)-alpha are the main players in
preventing the reactivation of tuberculosis. However, a study in Japan showed that levels of
TNF-alpha and IFN-gamma were significantly higher in ILD patients versus non-ILD patients
[9]. It is plausible that the acute and chronic exacerbations of parenchymal damage of the lungs
secondary to the ILD somehow inhibit the sustainment of granulomas via a non-cytokine
pathway, thus allowing the mycobacterium to reactivate and spread. This phenomenon may
have contributed to the rapid decline of our patient and his ultimate demise.
ILD with concomitant tuberculosis is a relatively rare occurrence, which may be challenging to
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diagnose. The symptoms of the ILD can often mask an underlying pulmonary infection and can
result in a misdiagnosis of the patient. Due to the rarity of having these two illnesses at the
same time, there are no established management protocols or algorithms. Current guidelines
recommend the initial test in all cases of suspected ILD to include a urine dipstick, full
differential blood cell count, serum urea, electrolytes and creatinine, and liver function tests.
Other tests, such as tuberculin tests, are largely dependent upon clinical context [10]. However,
a high clinical suspicion and, arguably, cases such as ours will demonstrate the importance of
ruling out an MTB infection as a standard for all ILD patients, especially in the indigenous
population.
Conclusions
Herein we presented an interesting case of ILD with concomitant tuberculosis, a rare
phenomenon which may present as a clinical challenge. As evidence suggests there is an
increased presence of tuberculosis in the setting of ILD. A diagnostic approach inclusive of
ruling out mycobacterium infection should be adopted. Clinicians involved in the management
of ILD should take consideration of possible concomitant infection.
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